Mor F, Lohse A W, Karin N, Cohen I R
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Isreal.
J Clin Invest. 1990 May;85(5):1594-8. doi: 10.1172/JCI114610.
Effective T cell vaccination against experimental autoimmune diseases involves treatment with activated, autoimmune T lymphocytes. The present study was undertaken to learn whether antigen-specific T cells present in low frequency could be selected in vitro without using the specific antigen. The rat models of adjuvant arthritis and experimental autoimmune encephalomyelitis were investigated using proliferation assays and limiting dilution techniques to quantify the changes in reactivity of a heterogenous population of lymphocytes to the relevant antigen. Stimulation with concanavalin A for 2 d and then culture in IL-2-containing medium led to a substantial increase in the activity and frequency of the specific autoimmune T cells. Enrichment of antigen-specific T cells could be demonstrated using lymph node, spleen, or peripheral blood lymphocytes, from rats late in the course of disease. The effect was not evident in lymphocytes from the thymus. These results are relevant to the clinical application of T cell vaccination and to investigation of self-antigens in autoimmune disease.
针对实验性自身免疫性疾病的有效T细胞疫苗接种涉及用活化的自身免疫性T淋巴细胞进行治疗。本研究旨在了解是否可以在不使用特异性抗原的情况下在体外选择低频存在的抗原特异性T细胞。使用增殖测定和有限稀释技术研究佐剂性关节炎和实验性自身免疫性脑脊髓炎的大鼠模型,以量化异质性淋巴细胞群体对相关抗原反应性的变化。用伴刀豆球蛋白A刺激2天,然后在含IL-2的培养基中培养,导致特异性自身免疫T细胞的活性和频率大幅增加。使用疾病晚期大鼠的淋巴结、脾脏或外周血淋巴细胞可以证明抗原特异性T细胞的富集。在来自胸腺的淋巴细胞中,这种效果不明显。这些结果与T细胞疫苗接种的临床应用以及自身免疫性疾病中自身抗原的研究相关。